7/8, 11:51 AM (Source: TeleTrader)
more TeleTrader news

India okays GSK, Sanofi COVID-19 vaccine trials

Indian health authorities approved on Thursday the start of the late-stage clinical trial of the COVID-19 vaccine developed by Sanofi S.A. and GlaxoSmithKline plc.

The two companies confirmed they are hoping to request the emergency use authorization for their vaccine before the end of the year, since the early studies showed the jab produces an immune response.

The worldwide vaccine trials have started two months ago, with Brazil being the latest country to initiate the third phase of clinical trials.

Breaking the News / ND